Leishmania amazonensis infection is reduced in macrophages treated with guanine ribonucleosides

Acta Tropica

Volumn 70, Issue 1, 1998, Pages 119-122

  Giorgio, Selma ^a   Barão, Sandra C ^a   Augusto, Ohara ^b   Kwee, Jolie K ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Guanosine analogues; Leishmania amazonensis; Macrophage

Indexed keywords

8 BROMOGUANOSINE; 8 MERCAPTOGUANOSINE; GUANOSINE DERIVATIVE; IMMUNOSTIMULATING AGENT; INTERFERON; LOXORIBINE;

ANIMAL CELL; CONTROLLED STUDY; DRUG POTENTIATION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SHORT SURVEY;

ANIMALIA; LEISHMANIA AMAZONENSIS;

EID: 0032526179     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(98)00012-6     Document Type: Article

References (14)

1. Bonnet, P.A., Robins, R.K., 1993. Modulation of leukocyte genetic expression by novel purine nucleoside analogues. A new approach to antitumor and antiviral agents. J. Med. Chem. 36, 635-653.
2. Cantos, G., Barbiéri, C.L., Iacomini, M., Gorin, P.A.J., Travassos, L.R., 1993. Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania -infected macrophage. Biochem. J. 289, 155-160.
3. Chance, M.L., 1995. New developments in the chemotherapy of leishmaniasis. Ann. Trop. Med. Parasitol. 89 (Suppl. 1), 37-43.
4. Chaudhuri, G., Mukhopadhyay, A., Basu, S.K., 1989. Selective delivery of drugs to macrophages through a highly specific receptor. Biochem. Pharmacol. 38, 2995-3002.
5. Goodman, M.G., 1991. Cellular and biochemical studies of substituted guanine ribonucleoside immunostimulants. Immunopharmacology 21, 51-68.
6. Goodman, M.G., 1995. A new approach to vaccine adjuvant: immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine. In: Powel, M.F., Newman, M.J. (Eds.), Vaccine Design. Plenum Press, New York, pp. 581-609.
7. Goodman, M.G., Weigle, W.O., 1983. Derivatized guanine nucleosides: a new class of adjuvant for in vitro antibody response. J. Immunol. 130, 2580-2585.
8. Goodman, M.G., Reitz, A.B., Chen, R., Bobardt, M.D., Goodman, J.H., Pope, B., 1995. Selective modulation of elements of the immune system by low molecular weight nucleosides. J. Pharmacol. Exp. Ther. 274, 1552-1557.
9. Koo, G.C., Jewell, M.E., Manyak, C.L., Sigal, N.H., Wicker, L.S., 1988. Activation of murine natural killer cells and macrophages by 8-bromoguanosine. J. Immunol. 140, 3249-3252.
10. Ojo-Amaize, E.A., Rubalcava, B., Avery, T.L., Cottan, H.B., Matsumoto, S.S., Jolley, W.B., Robins, R.K., 1990. Activation of respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at the 7 and 8 positions: possible involvement of a pertussis toxin-sensitive G-protein. Immunol. Lett. 23, 173-178.
11. Rabinovich, M., Dedet, J.P., Ryter, A., Ropbeneaux, R., Topper, G., Brunet, E., 1982. Destruction of Leishmania mexicana amazonensis amastigotes within macrophages in culture by phenazine methosulfate and other electron carriers. J. Exp. Med. 155, 415-431.
12. Shankar, A.H., Morin, P., Titus, R.G., 1996. Leishmania major; differential resistance to infection in C57BL/6 (high interferon-α/β) and congenic B6.C-H-28c (low interferon-α/β) mice. Exp. Parasitol. 84, 136-143.
13. 3H]thymidine incorporation by guanosine and deoxyguanosine in human lymphoid cells. Adv. Exp. Med. Biol. 195, 547-551.
14. Walton, B.C., 1987. American cutaneous and mucocutaneous leishmaniasis. In: Peters, W., Killick-Kendrich, R. (Eds.), The Leishmaniasis in Biology and Medicine, vol. 1. Academic Press, London, pp. 637-664.